journals.plos.org /2 weeks ago

A common pathogenic founder variant in Rwandan breast cancer cases

by Achille V. C. Manirakiza, Shakuntala Baichoo, Annette Uwineza, Damas Dukundane, Eulade Rugengamanzi, Janviere Mutamuliza, Allison M. O. Niragira, Raissa Muvunyi, Jeffrey Besada,...

Read source
aacr.org /1 month ago

Three Sisters, BRCA1 Mutations, and a Cancer Diagnosis While Pregnant

Carolyn Searles and her sisters all tested positive for a BRCA1 mutation and underwent double mastectomies to reduce their breast cancer risk. Still, Carolyn was diagnosed with bre...

Read source
bioengineer.org /1 month ago

Platinum Chemotherapy, Not PARP Inhibitors, Emerges as the Main Driver of Blood Clone Expansion

New research shows carboplatin drives the expansion of TP53-mutant blood clones far more strongly than PARP inhibitors, while inherited homologous recombination deficiency unexpect...

Read source
bioengineer.org /3 weeks ago

Ascites Cell Blocks Enable Ovarian Cancer Diagnosis and Molecular Profiling

A study of 58 patients found that ovarian cancer ascites-derived cell blocks supported immunohistochemical diagnosis and detected homologous recombination repair gene mutations in...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.